Form D · Pharmaceuticals
Recro Pharma, Inc.
Malvern, PA · CIK 0001588972
Offering snapshot reported Jul 13, 2015 · SEC filing
- Reported sold
- $16M Offering amount: $16M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 1, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2015 | Initial | $16,000,008 | No comparison | 3 | SEC filing |
| Apr 23, 2015 | Initial | $7,778,364 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $960K
- Finders' fees
- $0
- Form D file number
- 021-243567
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jefferies LLC | 2347 | |
| Brean Capital, LLC | 23723 | |
| Janney Montgomery Scott LLC | 463 | |
| MLV & Co. LLC | 150959 |
Source: Form D, filed Jul 13, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alfred Altomari | Director |
| William L Ashton | Director |
| Michael Berelowitz | Director |
| Winston J Churchill | Director |
| Charles Garner | Executive |
| Gerri A Henwood | Director, Executive |
| Abraham Ludomirski | Director |
| Donna Nichols | Executive |
| Wayne B Weisman | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
490 Lapp Road
Malvern, PA, 19355
Malvern, PA, 19355